Chemistry: analytical and immunological testing – Involving an insoluble carrier for immobilizing immunochemicals
Patent
1993-10-05
1995-12-05
Spiegel, Carol A.
Chemistry: analytical and immunological testing
Involving an insoluble carrier for immobilizing immunochemicals
422 57, 435 71, 435 792, 435 794, 435 795, 435970, 435975, 436528, 436531, 436532, 436808, 530359, 530380, 5303893, G01N 33543, G01N 3353
Patent
active
054728835
DESCRIPTION:
BRIEF SUMMARY
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a solid phase reagent obtained by binding .beta.2-glycoprotein I (.beta.2-GPI) to a specific carrier, an assay method for antibodies specific to antiphospholipid syndrome using the solid phase reagent, a method for detecting antibodies specific to antiphospholipid syndrome and antibodies specific to infectious diseases differentially from each other, and a kit for use in the method.
2. Description of Related Art
Various assay methods including RIA and ELISA for anticardiolipin antibodies which are antibodies of the antiphospholipid family had been reported by Harris et al. (Lancet, iii: 1211, 1983), by Koike et al. (Clin. Exp. Immunol., 56: 193, 1984), etc.
However, those methods described above are not necessarily satisfactory since they involve problems in that the anticardiolipin antibodies cannot be assayed quantitatively or they involve problems in that the antibodies associated with infectious diseases cannot be assayed differentially from antibodies found in patients with antiphospholipid syndrome.
Recently, Matsuura et al. found that anticardiolipin antibodies associated with antiphospholipid syndrome do not recognize an immobilized cardiolipin (CL) but the complex of cardiolipin and .mu.2-glycoprotein I (alternatively termed apolipoprotein H or anticardiolipin cofactor). Further, they developed an assay method for antiphospholipid antibody determination based on the new findings described above, which can overcome the prior art problems as described above (Lancet, 336: 177, 1990, RINSHO MEN-EKI (Clinical Immunology), 22 (Suppl. 15): 170, 1990, WO 91/06006, J. Immunol., 148:3855, 1992).
The studies by Matsuura et al. revealed that anticardiolipin antibodies associated with antiphospholipid syndrome recognize the complex of cardiolipin and .beta.2-glycoprotein I. However, clinical significance of the antibodies has been still unclear. Under these circumstances, clarifying the clinical significance of anticardiolipin antibody binding should elucidate the pathogenesis of antiphospholipid syndrome. This is an important issue to be focused on in the future.
To solve the above-mentioned problems, it is important to develop a more convenient assay method having a high specificity and quantitative property. However, according to the conventional RIA and ELISA methods, it was impossible to detect differentially the antibodies directed to the complex of cardiolipin and .beta.2-glycoprotein I which is found in the patient with antiphospholipid syndrome from those directed to cardiolipin associated with infectious diseases such as syphilis, as described above. Although, the assay method improved by Matsuura et al. could provide differential detection of those antibodies, the preparation of solid phase reagents was still complicated on the other hand. It has thus been desired to establish a more convenient assay method.
Accordingly, an object of the present invention is to provide an assay method in a simpler manner for antibodies specific to the complex of cardiolipin and .beta.2-glycoprotein I.
SUMMARY OF THE INVENTION
As a result of extensive studies to achieve the object described above, the present inventors have found that antibodies specific to antiphospholipid syndrome can be detected by using as a solid phase reagent a .beta.2-glycoprotein I-coated carrier whose surface bears functional groups containing a negative charge or a lone pair of electrons, and/or free radicals containing a negative charge or a lone pair of electrons. The present invention has thus been accomplished.
Accordingly, the present invention relates to a solid phase reagent comprising a .beta.2-glycoprotein I-coated carrier whose surface bears functional groups containing a negative charge or a lone pair of electrons, and/or free radicals containing a negative charge or a lone pair of electrons (hereinafter sometimes simply referred to as solid phase reagent I).
The present invention also relates to an assay method by using the solid phase rea
REFERENCES:
patent: 4299916 (1981-11-01), Litman et al.
patent: 4552633 (1985-11-01), Kumakura et al.
patent: 5016644 (1991-05-01), Guirguis
patent: 5028657 (1991-07-01), Hsu et al.
patent: 5102798 (1992-04-01), Guiseppi-Elie
patent: 5133363 (1992-07-01), Guirguis
patent: 5171779 (1992-12-01), Hsu et al.
patent: 5268287 (1993-12-01), Matsuki et al.
Chemical Abstract of JP-63-18268, vol. 109: 226254s (1988) p. 433.
Galli et al., "Anticardiolipin Antibodies (ACA) Directed Not to Cardiolipin But To A Plasma Protein Cofactor", Lancet 1990; 335: pp. 1544-1547.
American Journal of Medicine, "Association of Anti-.beta..sub.2 Glycoprotein I Antibodies With Lupus-Type Circulating Anticoagulant and Thrombosis in Systemic Lupus Erythematosus", Viard et al., vol. 93, No. 2, 1992 pp. 181-186.
E. Matsura et al., "Anticardiolipin Antibodies Recognize .beta.2-Glycoprotein I Structure Altered by Interacting with an Oxygen Modified Solid Phase Surface" in J. Exp. Medicine, vol. 179, Feb. 1994, pp. 457-462.
J. Arvieux et al. "Measurement of Anti-Phospholipid Antibodies by ELISA using .beta.2-glycoprotein I as an antigen", J. of Immunol. Methods 143 (1991): 223-229.
J. Hunt et al., "Identification of a region of .beta.2-glycoprotein I critical for lipid bending and anti-cardiolipin antibody . . . ", PNAS, USA 90 (1993): 2141-2145.
Igarashi Yoshiko
Koike Takao
Matsuura Eiji
Nagae Hisato
Koike Takao
Spiegel Carol A.
Yamasa Corporation
LandOfFree
Solid phase reagent and assay method for measuring antibodies sp does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Solid phase reagent and assay method for measuring antibodies sp, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solid phase reagent and assay method for measuring antibodies sp will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1373642